Employees: 1-10
Investment Stage: Series B
Portfolio 11
| Date | Name | Website | Total Raised | Location |
| 31.12.2022 | SalioGen T... | saliogen.com | $115M | United Sta... |
| 04.01.2019 | Candel The... | candeltx.com | $51.2M | United Sta... |
| - | Xalud Ther... | xaludthera.com | $30M | United Sta... |
| - | Taysha Gen... | tayshagtx.com | $125M | United Sta... |
| - | Acumen Pha... | acumenpharm.com | $160M | United Sta... |
| - | Verrica Ph... | verrica.com | $180M | United Sta... |
| - | ARCHERDX | archerdx.com | $150M | United Sta... |
| - | LEXEO Ther... | lexeotx.com | $180M | United Sta... |
| - | Dova Pharm... | dova.com | $75M | United Sta... |
| - | Enzymatics... | enzymatics.com | - | United Sta... |
Show more
Persons 3
| Date | First Name | Last Name | Title | Location | |||
| - | Joe | Pedersen | Partner | - | - | - | |
| - | Steven | M. Goldman | Managing P... | - | - | - | |
| - | Jayson | Rieger | Managing P... | - | - | - |
Mentions in press and media 8
| Date | Title | Description |
| 14.06.2022 | PBM Capital Rx raises $106M; Virtual surgery platform Proximie scores $80M | Photo: Proximie |
| 31.08.2021 | Digital health news, funding roundup in the prior week; August 30 | Headspace's resilience brand and Ginger's clinical heft create mental health powerhouse Bambi Francisco Roizen sits down with Russ Glass, CEO of newly-formed Headspace Health, the combination of Ginger, a provider of on-demand coaching, the... |
| 25.08.2021 | Daily funding roundup - August 24th, 2021 | Bridge to Life raised $56M; Covera Health landed $25M; Equum Medical secured $20M Ramp: Ramp is a New York-based corporate card and expense management platform. Ramp has raised $300 million in Series C funding. Founders Fund led the round, ... |
| 04.01.2019 | PBM Capital Group Leads $28.7M Series B for Candel Therapeutics | AUBURNDALE, Mass., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Candel Therapeutics, a clinical-stage biotechnology company developing novel cancer immunotherapy therapeutics, today announced the closing of a $28.7 million Series B financing led by PB... |
| 04.01.2019 | PBM Capital Group Leads $28.7M Series B for Candel Therapeutics | AUBURNDALE, Mass., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Candel Therapeutics, a clinical-stage biotechnology company developing novel cancer immunotherapy therapeutics, today announced the closing of a $28.7 million Series B financing led by PB... |
| 06.01.2017 | Dova Pharmaceuticals Announces Hiring of CEO and Presentation at the 35th Annual J.P. Morgan Healthcare Conference | CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–January 6, 2017– Dova Pharmaceuticals, Inc., a clinical, late-stage company, having recently completed enrollment in two global, pivotal Phase 3 trials, is pleased to announce the appointment of its new ... |
| 25.04.2014 | Gene therapy for spinal muscular atrophy secures funding to begin clinical trials | The company’s approach is to deliver functioning copies of the SMN gene to cells so they can produce adequate SMN proteins. It does that using a viral vector licensed from the company ReGenX. The upcoming trial will enroll nine infants with... |
| - | Gene therapy for spinal muscular atrophy secures funding to begin clinical trials | A Dallas biotech startup has raised money to begin clinical trials for what it hopes could be a treatment for the top genetic cause of infant mortality. AveXis is developing a viral gene therapy for infants with spinal muscular atrophy. Wit... |